Why do patients with low-grade soft tissue sarcoma die?

October 6th, 2008 by admin

Abstract
Introduction  The patterns of unfortunate and mechanisms of sarcoma-specific modification are poorly defined among the eld of patients with
low-grade fleecy paper sarcoma (STS) who consent to disease.

Methods  Between 1982 and 2006, 2,041 patients older ≥16 years with low-grade STS of every sites were aerated with sanative aim and
prospectively followed at a azygos institution.

Results  Among this cohort, 181 (9%) died from disease (DOD). Overall, 105 patients (58%) died from locally continual disease (DOLR),
and 59 (32%) died from extreme disease (DODR). In 17 patients (9%), the execution of sarcoma-related modification could not be verified.
DOD occurred at a norm of 62 months, patch norm disease-specific activity for the whole people was not reached. Median
follow-up was 66 months (range 2–431 months). On multivariate analysis, DOD was related with site, size, and inferior than
R0 resection. For DOLR, site, size, constructive margins, liposarcoma histology, and topical repetition (by definition) were significant
factors. For DODR, site, histology, and constructive margins were not momentous factors, patch filler and topical repetition were.
Of DOLR, 80% were retroperitoneal, 68% were liposarcoma, and exclusive 2% were extremity. Conversely, of DODR, member (47%)
and luggage (18%) were the most ordinary sites, but histology was more uncertain [liposarcoma 35%, cancerous tough histiocytoma
(MFH) 20%, fibrosarcoma 12%, extraskeletal myxoid chondrosarcoma 10%]. High-grade repetition rates were same between
DOLR (27%) and DODR (25%).

Conclusion  Among patients with low-grade STS, DOD occurs in roughly 9% of patients. Nonextremity site, large size, and inferior than
R0 resection are the most essential venture factors for DOD, and crisp patterns of repetition and modification are predicted by primary
growth site.

Content Type Journal ArticleCategory Bone and Soft Tissue SarcomasDOI 10.1245/s10434-008-0163-0Authors
Robert J. Canter, Memorial Sloan-Kettering person Center Department of Surgery 410 E. 68th Street New royalty NY 10065 USALi-Xuan Qin, Memorial Sloan-Kettering person Center Epidemiology and Biostatistics New royalty NY USACristina R. Ferrone, Memorial Sloan-Kettering person Center Department of Surgery 410 E. 68th Street New royalty NY 10065 USARobert G. Maki, Memorial Sloan-Kettering person Center Department of Medicine, Melanoma-Sarcoma Service New royalty NY USASamuel Singer, Memorial Sloan-Kettering person Center Department of Surgery 410 E. 68th Street New royalty NY 10065 USAMurray F. Brennan, Memorial Sloan-Kettering person Center Department of Surgery, Benno C. solon Chair in Clinical Oncology 410 E. 68th Street New royalty NY 10065 USA

Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)

Tags: , , , , , ,

Posted in Cancer |

Related posts

Comments are closed.